Thymosin Beta-4 (TB4), commercially referenced as TB500 in research settings, is one of the most abundant and ubiquitous intracellular peptides in the human body. Present in virtually every cell type, TB4 plays a central role in cytoskeletal dynamics, cell migration, and tissue repair — making it a foundational compound in regenerative biology and wound healing research.
What Is TB500 (Thymosin Beta-4)?
Thymosin Beta-4 is a naturally occurring 43-amino acid peptide encoded by the TMSB4X gene. It was first isolated from thymic tissue but is now known to be expressed ubiquitously across virtually all cell types. Its primary biological role is as the major actin-sequestering molecule in eukaryotic cells, binding G-actin monomers and regulating the dynamic equilibrium between monomeric and filamentous actin.
Key Areas of In Vitro Research
Actin Sequestration and Cytoskeletal Dynamics
TB4’s most well-characterized function is its role as the primary G-actin sequestering peptide in cells. In vitro studies have demonstrated that TB4 binds actin monomers with high affinity, regulating the pool of available actin for polymerization. This control over cytoskeletal dynamics has downstream effects on cell shape, motility, and division — making TB4 an essential research tool for studying cytoskeletal biology.
Cell Migration and Wound Healing
In vitro scratch assay studies have consistently demonstrated that TB4 significantly accelerates cell migration in multiple cell line models including keratinocytes, fibroblasts, and endothelial cells. Research has shown that TB4-treated cells exhibit enhanced lamellipodia formation and directional migration, key processes in wound closure and tissue repair. These findings have established TB4 as a benchmark compound in wound healing research.
Angiogenesis via VEGF Pathways
TB4 has been studied extensively for its pro-angiogenic properties. In vitro research has demonstrated that TB4 upregulates VEGF (vascular endothelial growth factor) expression and promotes endothelial cell tube formation in Matrigel assays. Studies have also examined its activation of the PI3K/Akt signaling pathway in endothelial cells, providing mechanistic insight into its angiogenic activity.
Anti-Inflammatory Effects
In vitro research has investigated TB4’s ability to reduce pro-inflammatory cytokine production in macrophage and epithelial cell models. Studies have shown decreased NF-κB activation and reduced IL-1β, TNF-α, and IL-6 secretion in TB4-treated cell lines, positioning it as a valuable tool for studying peptide-mediated anti-inflammatory mechanisms.
MMP Upregulation and Matrix Remodeling
TB4 has been shown in vitro to upregulate matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9, which are critical for extracellular matrix remodeling during tissue repair. This MMP-stimulating activity, combined with its cell migration-promoting effects, makes TB4 a comprehensive research tool for studying the multi-step process of tissue regeneration at the cellular level.
TB500 in Combination Research Blends
TB500 is also available in combination research formulations at Everlast Research. The WOLVERINE 10MG blend (BPC-157 5mg + TB4 5mg) allows researchers to study synergistic interactions between two of the most studied regenerative peptides. The GLOW blend (BPC-157 10mg + GHK-Cu 50mg + TB4 10mg) provides a triple-peptide tool for comprehensive skin biology and tissue repair research.
TB500 at Everlast Research
Everlast Research supplies TB500 (Thymosin Beta-4) as a high-purity (≥98% HPLC verified) lyophilized powder in 10mg quantities, providing researchers with a reliable source for cytoskeletal, wound healing, and angiogenesis studies.
Research Compliance Note
All TB500 products from Everlast Research are strictly for in vitro laboratory research use only. Not for human or veterinary use. Use only in certified laboratory environments under proper compliance.
Everlast Research supplies high-purity lyophilized research compounds for qualified laboratory professionals. All products are for in vitro research use only.